These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7363464)

  • 101. A discrete analyzer (ABA-100) method for prostatic acid phosphatase with thymolphthalein monophosphate as substrate.
    Chu SY; Turkington VE
    Clin Chem; 1982 Feb; 28(2):389-90. PubMed ID: 7055971
    [No Abstract]   [Full Text] [Related]  

  • 102. Clinical significance of serum acid phosphatase as measured by ELISA after treatment of benign prostatic hyperplasia.
    Cooper EH; Pidcock NB; Glashan R; Smith PH; Robinson MR; Richards B; Newling D
    Clin Chem; 1982 Jul; 28(7):1729-30. PubMed ID: 7083588
    [No Abstract]   [Full Text] [Related]  

  • 103. Grossly elevated serum prostatic acid phosphatase in a patient with carcinoid.
    Staley MJ; Kunde D; Cook SJ; Rainbow RD; Kimber R
    Pathology; 1990 Apr; 22(2):115-8. PubMed ID: 2235095
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Stability of immunologic activity of human prostatic acid phosphatase in serum.
    Chen IW; Sperling MI; Maxon HR; Kaplan LA
    Clin Chem; 1982 May; 28(5):1163-6. PubMed ID: 7200413
    [TBL] [Abstract][Full Text] [Related]  

  • 105. The prostate of the gorilla.
    Jacobs SC; Beehler BA; Boese G; Story MT; Clowry LJ; Lawson RK
    Prostate; 1984; 5(6):597-603. PubMed ID: 6494058
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Comparison of assays for prostatic and total acid phosphatase.
    Saw D; Schwartz MK; Smith C; Schwartz DC; Fleisher M; Levine J
    Clin Biochem; 1990 Dec; 23(6):505-8. PubMed ID: 2289308
    [TBL] [Abstract][Full Text] [Related]  

  • 107. An optimized continuous-monitoring procedure for semiautomated determination of serum acid phosphatase activity.
    Bais R; Edwards JB
    Clin Chem; 1976 Dec; 22(12):2025-8. PubMed ID: 11900
    [TBL] [Abstract][Full Text] [Related]  

  • 108. 1-naphthyl phosphate: specifications for high-quality substrate for measuring prostatic acid phosphatase activity.
    Bowers JL; Bowers GN
    Clin Chem; 1982 Jan; 28(1):212-5. PubMed ID: 7198943
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Stability of prostatic acid posphatase in normal human sera.
    Josephson L; Houle P
    Clin Chem; 1980 Oct; 26(11):1631. PubMed ID: 7418222
    [No Abstract]   [Full Text] [Related]  

  • 110. Effects of substrate concentration on results of determination of prostatic acid phosphatase with thymolphthalein monophosphate.
    Kessner A; Woodard EJ; Bowers GN
    Clin Chem; 1983 Jan; 29(1):148-51. PubMed ID: 6681535
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer.
    Kanyong P; Rawlinson S; Davis J
    J Cancer; 2016; 7(5):523-31. PubMed ID: 26958088
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Urology-epitomes of progress: detection of specific prostatic Acid phosphatase.
    Nachtsheim DA
    West J Med; 1981 Apr; 134(4):346-7. PubMed ID: 18748852
    [No Abstract]   [Full Text] [Related]  

  • 113. The immunohistochemical detection of prostatic acid phosphatase: its possibilities and limitations in tumour histochemistry.
    Jöbsis AC; De Vries GP; Meijer AE; Ploem JS
    Histochem J; 1981 Nov; 13(6):961-73. PubMed ID: 6175605
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
    Debruyne FM; van Munster PJ; van Groeninghen JC; Kirkels WJ
    Urol Res; 1984; 12(5):233-7. PubMed ID: 6083652
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Serum tissue polypeptide antigen (TPA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
    Marczyńska A; Kulpa J; Leńko J; Augustyn M
    Int Urol Nephrol; 1988; 20(2):123-9. PubMed ID: 2454895
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Prostate-specific acid phosphatase: re-evaluation of radioimmunoassay in diagnosing prostatic disease.
    Griffiths JC
    Clin Chem; 1980 Mar; 26(3):433-6. PubMed ID: 7363464
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for prostate-specific acid phosphatase in prostatic disease.
    Griffiths J; Rippe DF; Panfili PR
    Clin Chem; 1982 Jan; 28(1):183-6. PubMed ID: 7055908
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Radioimmunoassay of prostatic acid phosphatase: validation and clinical application.
    Franchimont P; Bouffioux C; Reuter A; Rigo-Betz C; Vrindts-Gevaert Y; Jaspar JM; Lecomte-Yerna MJ
    Int J Cancer; 1983 Feb; 31(2):149-55. PubMed ID: 6826245
    [No Abstract]   [Full Text] [Related]  

  • 119. Immunological and clinical specificity of the immunochemical determination of prostatic acid phosphatase.
    Shaw LM; Yang N; Neat M; Croop W
    Ann N Y Acad Sci; 1982; 390():73-88. PubMed ID: 6178344
    [No Abstract]   [Full Text] [Related]  

  • 120. Acid phosphatase.
    Henneberry MO; Engel G; Grayhack JT
    Urol Clin North Am; 1979 Oct; 6(3):629-41. PubMed ID: 388794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.